Epidemiology and burden of mild/moderate versus high myopia in Germany: A claims data analysis

Garcia TB, Kossack N, Pignot M, Dagher M, Schuster AK, Wielink KS.

2025
Acta Ophthalmol.

Therapeutic Area

Back of the eye (BOTE)
Categories

Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

Affiliations

WIG2 - Scientific Institute for Health Economics and Health System Research, Leipzig, Germany; ZEG - Berlin Center for Epidemiology and Health Research, Berlin, Germany; Department of Ophthalmology, University Medical Center Mainz, Mainz, Germany; Santen SA, Amsterdam, Netherlands.

Related Publications

Consensus on evidence gaps and unmet needs in childhood myopia: findings from a European Delphi study with eye care professionals and payers

Lagreze W, Nucci P, Versteegh M, Klaver C, Barrio-Barrio J, Dahlmann-Noor A, Gomez de Liaño R, Ghorbani-Mojarrad N, Kessel L, Polling JR, Sauer A, Schuster AK, Serafino M, Villani E, Ziemssen F, Boehler YB, Capri S, Gianfrate F, Valles Callol JA, Wong O, Chen TY, Lymperopoulou C, Palaka I, Punekar Y, von Bredow D, Shi-van Wielink K.

Economic evaluation, resource utilisation, and associated economic burden of myopia management: a systematic literature review

de Milliano T. WL, Shi-van Wielink K., Ernst F., Mulkalapalli N., Pagidigummula R., Lymperopoulou C.

Efficacy and Safety of Low-Concentration Atropine in Slowing Myopia Progression in Children in Japan: The Randomized, Double-Blind Phase II/III ORANGE Study

Ohno-Matsui K., Igarashi-Yokoi T., Migita Y., Yamakawa Y, on behalf of the ORANGE study investigators

View all Back of the eye (BOTE) publications